UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934(1)
(Amendment No.     )*

 

APPLIED GENETIC TECHNOLOGIES CORPORATION

(Name of Issuer)

Common Stock

(Title of Class of Securities)

03820J100

(CUSIP Number)

March 14, 2019

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

 

CUSIP No. 03820J100

 

 

1

Name of Reporting Persons
Stichting Aescap 2.0

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

4

Citizenship or Place of Organization
The Netherlands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5

Sole Voting Power
1,323,615

 

6

Shared Voting Power
0

 

7

Sole Dispositive Power
1,323,615

 

8

Shared Dispositive Power
0

 

 

9

Aggregate Amount Beneficially Owned by Each Reporting Person
1,323,615

 

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11

Percent of Class Represented by Amount in Row (9)
7.3%

 

 

12

Type of Reporting Person (See Instructions)
FI

 


(1) Based upon 18,165,054 shares of the Issuer’s Common Stock outstanding as of February 7, 2019, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on February 7, 2019.

 

2


 

 

1

Name of Reporting Persons
Privium Fund Management B.V.

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

4

Citizenship or Place of Organization
The Netherlands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5

Sole Voting Power
1,323,615

 

6

Shared Voting Power
0

 

7

Sole Dispositive Power
1,323,615

 

8

Shared Dispositive Power
0

 

 

9

Aggregate Amount Beneficially Owned by Each Reporting Person
1,323,615

 

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11

Percent of Class Represented by Amount in Row (9)
7.3%

 

 

12

Type of Reporting Person (See Instructions)
FI

 


(1) Based upon 18,165,054 shares of the Issuer’s Common Stock outstanding as of February 7, 2019, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on February 7, 2019.

 

3


 

 

1

Name of Reporting Persons
Patrick Johan Hendrik Krol

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

4

Citizenship or Place of Organization
The Netherlands

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5

Sole Voting Power
1,323,615

 

6

Shared Voting Power
0

 

7

Sole Dispositive Power
1,323,615

 

8

Shared Dispositive Power
0

 

 

9

Aggregate Amount Beneficially Owned by Each Reporting Person
1,323,615

 

 

10

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o

 

 

11

Percent of Class Represented by Amount in Row (9)
7.3%

 

 

12

Type of Reporting Person (See Instructions)
IN

 


(1) Based upon 18,165,054 shares of the Issuer’s Common Stock outstanding as of February 7, 2019, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on February 7, 2019.

 

4


 

Item 1.

 

(a).

Name of Issuer
Applied Genetic Technologies Corporation (the “Issuer”)

 

(b).

Address of Issuer’s Principal Executive Offices:
14193 NW 119
th Terrance, Suite 10, Alachua, Florida 32615

 

Item 2(a).

Name of Person Filing

Item 2(b).

Address of Principal Business Office

Item 2(c).

Citizenship

(i) Stichting Aescap 2.0 (“Aescap 2.0”)
Hoogoorddreef 15
1101BA Amsterdam

The Netherlands
Citizenship: The Netherlands

(ii) Privium Fund Management B.V. (“Privium”), as the fund manager of Aescap 2.0
Gustav Mahlerplein 3
1082 MS Amsterdam
The Netherlands
Citizenship: The Netherlands

 

(iii) Patrick Johan Hendrik Krol (“Krol”), the portfolio manager for Privium
Gustav Mahlerplein 3
1082 MS Amsterdam
The Netherlands
Citizenship: The Netherlands

 

The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”

Item 2(d).

Title of Class of Securities:
Common Stock (the “Shares”)

Item 2(e).

CUSIP Number:
03820J100

 

Item 3.

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

This Item 3 is not applicable.

 

5


 

Item 4.

Ownership.

 

(a)

Amount beneficially owned:   

Aescap 2.0 directly held 1,323,615 Shares.
Privium may be deemed to beneficially own the 1,323,615 Shares held by Aescap 2.0.
As the portfolio manager of Privium, Krol may be deemed to beneficially own the 1,323,615 Shares held by Aescap 2.0.

 

(b)

Percent of class:   

Aescap 2.0 may be deemed the beneficial owner of approximately 7.3% of the Shares outstanding.
Privium may be deemed the beneficial owner of approximately 7.3% of the Shares outstanding.
Krol may be deemed the beneficial owner of approximately 7.3% of the Shares outstanding.

 

(c)

Number of shares as to which the Reporting person has:

Aescap 2.0:

 

 

(i)

Sole power to vote or to direct the vote:   

1,323,615

 

 

(ii)

Shared power to vote or to direct the vote:    

0

 

 

(iii)

Sole power to dispose or to direct the disposition of:   

1,323,615

 

 

(iv)

Shared power to dispose or to direct the disposition of:   

0

 

 

Privium:

 

 

(i)

Sole power to vote or to direct the vote:   

1,323,615

 

 

(ii)

Shared power to vote or to direct the vote:    

0

 

 

(iii)

Sole power to dispose or to direct the disposition of:   

1,323,615

 

 

(iv)

Shared power to dispose or to direct the disposition of:   

0

 

 

Krol:

 

 

(i)

Sole power to vote or to direct the vote:   

1,323,615

 

 

(ii)

Shared power to vote or to direct the vote:    

0

 

 

(iii)

Sole power to dispose or to direct the disposition of:   

1,323,615

 

 

(iv)

Shared power to dispose or to direct the disposition of:   

0

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:   o

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

This Item 6 is not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

This Item 7 is not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

This Item 8 is not applicable.

 

Item 9.

Notice of Dissolution of Group.

This Item 9 is not applicable.

 

6


 

Item 10.

Certification.

Each of the Reporting Persons hereby makes the following certification:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

STICHTING AESCAP 2.0

 

BY: PRIVIUM FUND MANAGEMENT B.V., ITS FUND MANAGER

 

By:

/s/ Patrick Johan Hendrik Krol

 

Name:

P.J.H. Krol

 

Title:

Portfolio Manager

 

 

 

 

PRIVIUM FUND MANAGEMENT B.V.

 

 

 

 

By:

/s/ Patrick Johan Hendrik Krol

 

Name:

P.J.H. Krol

 

Title:

Portfolio Manager

 

 

 

 

PATRICK JOHAN HENDRIK KROL

 

 

 

 

 

/s/ Patrick Johan Hendrik Krol

 

 

Dated: March 26, 2019

 

7


Exhibit 99.1

 

Joint Filing Agreement

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.

 

Date: March 26, 2019

 

STICHTING AESCAP 2.0

 

BY: PRIVIUM FUND MANAGEMENT B.V., ITS FUND MANAGER

 

By:

/s/ Patrick Johan Hendrik Krol

 

Name:

P.J.H. Krol

 

Title:

Portfolio Manager

 

 

 

 

PRIVIUM FUND MANAGEMENT B.V.

 

 

 

 

By:

/s/ Patrick Johan Hendrik Krol

 

Name:

P.J.H. Krol

 

Title:

Portfolio Manager

 

 

 

 

PATRICK JOHAN HENDRIK KROL

 

 

 

 

 

/s/ Patrick Johan Hendrik Krol